Allspring Global Investments
JANX icon

Allspring Global Investments’s Janux Therapeutics JANX Stock Holding History

Allspring Global Investments’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43M Sell
166,092
-2,884
-2% -$41.8K ﹤0.01% 1032
2026
Q1 		$2.45M Buy
+168,976
New +$2.32M ﹤0.01% 1012
2025
Q4 		– Sell
-8,454
Closed -$207K – 1728
2025
Q3 		$207K Buy
+8,454
New +$206K ﹤0.01% 1546
2025
Q2 		– Sell
-9,033
Closed -$244K – 1718
2025
Q1 		$244K Buy
9,033
+3,168
+54% +$119K ﹤0.01% 1622
2024
Q4 		$314K Buy
5,865
+14
+0.2% +$741 ﹤0.01% 1568
2024
Q3 		$266K Sell
5,851
-433
-7% -$18.8K ﹤0.01% 1624
2024
Q2 		$263K Sell
6,284
-65
-1% -$3.05K ﹤0.01% 1650
2024
Q1 		$239K Sell
6,349
-19,915
-76% -$434K ﹤0.01% 1673
2023
Q4 		$282K Buy
26,264
+25,105
+2,166% +$217K ﹤0.01% 1623
2023
Q3 		$11.7K Buy
+1,159
New +$13.4K ﹤0.01% 2594
2022
Q2 		– Sell
-4,742
Closed -$68K – 2810
2022
Q1 		$68K Sell
4,742
-615
-11% -$10.1K ﹤0.01% 2807
2021
Q4 		$105K Buy
+5,357
New +$112K ﹤0.01% 2761

Other funds holding JANX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Allspring Global Investments's JANX Position: Q2 2026 in Review

Allspring Global Investments reduced its Janux Therapeutics (JANX) stake by 1.7% in Q2 2026, selling an estimated $41.8K and leaving 166,092 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1032.

Allspring Global Investments first reported a position in JANX in Q4 2021 and has held it in 12 quarters since. The position peaked at $2.45M in Q1 2026. 112 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Allspring Global Investments held 166,092 shares of Janux Therapeutics worth $2.43M as of Q2 2026.
  • Allspring Global Investments sold 2,884 Janux Therapeutics shares in Q2 2026, an estimated $41.8K.
  • Janux Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1032 holding.
  • Allspring Global Investments first reported a position in Janux Therapeutics in Q4 2021 and has held it in 12 quarters since.
  • Allspring Global Investments's Janux Therapeutics position peaked at $2.45M in Q1 2026.
  • 112 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.